Estados financieros detallados de Creative Medical Technology Holdings, Inc. (CELZ): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Creative Medical Technology Holdings, Inc. registró ingresos de $6000 en el último ejercicio fiscal, con un CAGR de 5 años del -48.4%.
Márgenes de los últimos 12 meses: margen bruto -17.3%, margen operativo -2080.0%, margen neto -2013.6%.
Al precio actual de $0.82, CELZ presenta beneficios negativos (P/E no significativo) y un ROE del -86.70%. La capitalización bursátil es de $2M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | 0 | $4800 | $124400 | $165500 | $164500 | $87754 | $88600 | $9000 | $11000 | $6000 |
| Coste de Ventas | $766072 | $8000 | $70375 | $45499 | $50596 | $47949 | $28491 | $3600 | $4400 | $2194 |
| Beneficio Bruto | -$766072 | -$3200 | $54025 | $120001 | $113904 | $39805 | $60109 | $5400 | $6600 | $3806 |
| I+D | $85334 | $260085 | $96621 | 0 | 0 | $109180 | $6.3M | $2.0M | $2.4M | $2.3M |
| Generales y Administrativos | $664984 | $898526 | $1.1M | $1.2M | $1.2M | $3.0M | $3.9M | $3.6M | $3.2M | $3.8M |
| Gastos Operativos | $759674 | $1.2M | $1.2M | $1.3M | $1.2M | $3.2M | $10.3M | $5.6M | $5.8M | $6.1M |
| Beneficio Operativo | -$766072 | -$1.2M | -$1.1M | -$1.1M | -$1.1M | -$3.1M | -$10.2M | -$5.6M | -$5.7M | -$6.1M |
| EBITDA | -$750318 | -$1.2M | -$1.1M | -$6.6M | -$35.0M | $23.6M | -$10.1M | -$5.2M | -$5.4M | -$6.0M |
| Gastos por Intereses | $6398 | $377587 | $1.4M | $1.9M | $1.2M | $4.3M | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$766072 | -$2.7M | -$13.7M | -$8.5M | -$36.3M | $19.2M | -$10.1M | -$5.3M | -$5.5M | -$6.0M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$766072 | -$2.7M | -$13.7M | -$8.5M | -$36.3M | $19.2M | -$10.1M | -$5.3M | -$5.5M | -$6.0M |
| BPA | $-5471.94 | $-17379.79 | $-11351.33 | $-5017.67 | $-626.88 | $73.75 | $-9.28 | $-3.76 | $-3.71 | $-2.52 |
| BPA Diluido | $-5471.94 | $-17379.79 | $-11351.33 | $-5017.67 | $-626.88 | $56.10 | $-9.28 | $-3.76 | $-3.71 | $-2.52 |
| Acciones en Circulación (Diluidas) | $140 | $153 | $1203 | $2068 | $57946 | $324861 | $1.1M | $1.4M | $1.5M | $2.4M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | 0 | $3000 | 0 | 0 |
| Beneficio Bruto | -$31059 | $2006 | 0 | -$22918 |
| Beneficio Operativo | -$1.3M | -$1.9M | -$1.5M | -$1.6M |
| EBITDA | -$1.2M | -$1.9M | -$1.4M | -$1.5M |
| Beneficio Neto | -$1.2M | -$1.9M | -$1.4M | -$1.5M |
| BPA | $-0.48 | $-0.73 | $-0.38 | $-0.41 |
| BPA Diluido | $-0.48 | $-0.73 | $-0.38 | $-0.41 |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $221868 | $13697 | $304056 | $88648 | $98012 | $10.7M | $8.3M | $3.5M | $5.9M | $7.2M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | $10.1M | $6.5M | 0 | 0 |
| Cuentas por Cobrar | 0 | $4801 | $9600 | $5600 | 0 | $2485 | 0 | 0 | 0 | $52084 |
| Inventario | 0 | 0 | 0 | 0 | 0 | $10866 | $10194 | $6594 | $2194 | 0 |
| Activos Corrientes | $221868 | $18498 | $313656 | $94248 | $98012 | $10.7M | $18.7M | $10.3M | $6.1M | $7.4M |
| Inmovilizado Material | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | $100644 | $184649 | $163505 | $436555 | $619763 | $527679 | $435595 | $441011 | $530559 | $407230 |
| Activos Totales | $322512 | $203147 | $477161 | $530803 | $717775 | $11.3M | $19.2M | $10.7M | $6.7M | $7.8M |
| Cuentas por Pagar | $66385 | $237566 | $331838 | $320785 | $350899 | $761862 | $3.3M | $317280 | $273530 | $270686 |
| Deuda a Corto | $102600 | $501748 | $682056 | $1.1M | $788701 | 0 | 0 | 0 | 0 | $14194 |
| Pasivos Corrientes | $453864 | $2.4M | $4.5M | $8.6M | $40.5M | $1.1M | $3.3M | $371394 | $327644 | $284880 |
| Deuda a Largo | $25000 | $915 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $480303 | $2.4M | $4.5M | $8.6M | $40.5M | $1.1M | $3.3M | $371394 | $327644 | $284880 |
| Reservas | -$766572 | -$3.4M | -$17.1M | -$25.6M | -$61.9M | -$43.7M | -$53.8M | -$59.1M | -$64.6M | -$70.6M |
| Patrimonio Neto | -$157791 | -$2.2M | -$4.0M | -$8.1M | -$39.8M | $10.2M | $15.9M | $10.3M | $6.3M | $7.5M |
| Deuda Total | $125000 | $513463 | $682056 | $1.1M | $788701 | 0 | 0 | 0 | 0 | $14194 |
| Deuda Neta | -$96868 | $499766 | $378000 | $973618 | $690689 | -$10.7M | -$18.4M | -$10.0M | -$5.9M | -$7.2M |
| Capital Circulante | -$231996 | -$2.4M | -$4.2M | -$8.5M | -$40.4M | $9.7M | $15.4M | $9.9M | $5.8M | $7.1M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $5.4M | $7.2M | $5.7M | $8.7M |
| Activos Totales | $5.9M | $7.8M | $6.4M | $9.4M |
| Pasivos Totales | $261353 | $284880 | $307649 | $698595 |
| Patrimonio Neto | $5.6M | $7.5M | $6.1M | $8.7M |
| Deuda Total | $14194 | $14194 | $14194 | 0 |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$766072 | -$2.7M | -$13.7M | -$8.5M | -$36.3M | $19.2M | -$10.1M | -$5.3M | -$5.5M | -$6.0M |
| Amortizaciones | $9356 | $15995 | $21144 | $26950 | $66792 | $92084 | $92084 | $94584 | $110452 | $121743 |
| Compensación en Acciones | $2565 | $144160 | $1877 | 0 | $170323 | $595380 | $68746 | $36648 | $36648 | $3485 |
| Cambio en Capital Circulante | $308919 | $158062 | $129426 | $62202 | $692794 | $249465 | $2.2M | -$2.8M | $45089 | $13335 |
| Flujo de Caja Operativo | -$445232 | -$889621 | -$1.1M | -$1.2M | -$434556 | -$2.2M | -$7.8M | -$8.0M | -$5.3M | -$5.9M |
| Inversiones (CapEx) | -$10000 | 0 | 0 | $3 | -$250000 | 0 | 0 | -$100000 | 0 | -$5 |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -$270952 | -$174964 | -$10000 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$455232 | -$889621 | -$1.1M | -$1.2M | -$684556 | -$2.2M | -$7.8M | -$8.1M | -$5.3M | -$5.9M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$1.2M | -$1.9M | -$1.3M | -$1.5M |
| Inversiones (CapEx) | 0 | $4 | 0 | 0 |
| Flujo de Caja Libre | -$1.2M | -$1.9M | -$1.3M | -$1.5M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | 0 | 0 | 0 | 0 |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | | +2491.7% | +33.0% | -0.6% | -46.7% | +1.0% | -89.8% | +22.2% | -45.5% |
| Crecimiento Beneficio Neto (anual) | | -247.1% | -413.5% | +37.9% | -328.2% | +152.9% | -152.8% | +47.9% | -3.9% | -9.1% |
| Crecimiento BPA (anual) | | -217.6% | +34.7% | +55.8% | +87.5% | +111.8% | -112.6% | +59.5% | +1.3% | +32.1% |
| Cambio en Acciones (anual) | | +9.3% | +686.3% | +71.9% | +2702.0% | +460.6% | +236.5% | +28.8% | +5.2% | +61.0% |
| Crecimiento FCF (anual) | | -95.4% | -18.3% | -15.3% | +43.6% | -223.7% | -251.9% | -4.2% | +34.8% | -10.5% |
| Margen Bruto | | -66.7% | 43.4% | 72.5% | 69.2% | 45.4% | 67.8% | 60.0% | 60.0% | 63.4% |
| Margen Operativo | | -24537.6% | -895.7% | -682.9% | -677.7% | -3562.2% | -11562.5% | -62445.9% | -52216.9% | -102380.2% |
| Margen EBITDA | | -24204.4% | -878.7% | -3964.5% | -21294.1% | 26873.2% | -11345.3% | -57688.8% | -48936.6% | -100324.8% |
| Margen Neto | | -55398.1% | -10977.2% | -5126.1% | -22082.2% | 21892.8% | -11449.3% | -58739.7% | -49940.7% | -99916.8% |
| Margen FCF | | -18533.8% | -845.9% | -733.0% | -416.1% | -2525.0% | -8800.2% | -90309.8% | -48193.6% | -97607.4% |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | 0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-3251.66 | $-5814.52 | $-874.70 | $-586.60 | $-11.81 | $-6.82 | $-7.13 | $-5.77 | $-3.58 | $-2.46 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $140 | $153 | $1203 | $2068 | $57946 | $260505 | $1.1M | $1.4M | $1.5M | $2.4M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -86.70% |
| Rentabilidad sobre capital invertido | -71.90% |
| Rentabilidad sobre activos | -64.42% |
| Margen bruto | -1732.37% |
| Margen operativo | -208004.40% |
| Margen neto | -201355.37% |
Salud financiera
| Deuda / Patrimonio | 0.00 |
| Ratio corriente | 12.91 |
| Piotroski F-Score | 3 |
| Altman Z-Score | -4.32 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -63.60 | -0.50 | -0.65 | -0.04 | -0.22 | 0.30 | -0.41 | -1.23 | -0.62 | -0.78 |
| P/VC | -308.76 | -0.59 | -2.23 | -0.06 | -0.20 | 0.56 | 0.26 | 0.63 | 0.54 | 0.62 |
| P/V | 0.00 | 274.92 | 71.66 | 2.81 | 48.96 | 65.61 | 47.01 | 721.02 | 310.89 | 778.38 |
| Margen Bruto | 0.0% | -66.7% | 43.4% | 72.5% | 69.2% | 45.4% | 67.8% | 60.0% | 60.0% | 63.4% |
| Margen Operativo | 0.0% | -24537.6% | -895.7% | -682.9% | -677.7% | -3562.2% | -11562.5% | -62445.9% | -52216.9% | -102380.2% |
| Margen Neto | 0.0% | -55398.1% | -10977.2% | -5126.1% | -22082.2% | 21892.8% | -11449.3% | -58739.7% | -49940.7% | -99916.8% |